Position in REGN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$7,262,370
-$1,807,650 QoQ
Shares Held
11,647
-0.8% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#338
of 1,322 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 71%
Shared 0%
None 29%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Lido Advisors, LLC holds $48,509,639 across 38 Biotechnology names. REGN ranks #2 (15.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
45,347 | $22,525,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
11,647 | $7,262,370 | |
| 3 | INCY |
Incyte Corp
|
18,327 | $2,077,548 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
51,212 | $1,908,671 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
8,476 | $1,587,385 | |
| 6 | TARS |
Tarsus Pharmaceuticals, Inc.
|
24,322 | $1,530,826 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,158 | $1,410,609 | |
| 8 | MRNA |
Moderna, Inc.
|
16,522 | $1,157,035 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,262,370 | 11,647 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $9,070,020 | 11,739 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $10,356,178 | 13,417 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $6,829,331 | 12,146 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,977,800 | 5,672 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $2,668,839 | 4,208 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,648,331 | 2,314 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,221,269 | 2,113 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,033,742 | 1,935 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $1,788,305 | 1,858 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,475,527 | 1,680 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,194,114 | 1,451 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,515,400 | 2,109 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,161,841 | 1,414 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $575,749 | 798 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $444,321 | 645 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $388,372 | 657 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $616,704 | 883 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $413,645 | 655 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $448,438 | 741 | Shares | Sole | 2022-02-15 | |
| 2021-06-30 | $352,438 | 631 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $454,214 | 960 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $265,227 | 549 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $359,378 | 642 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $253,825 | 407 | Shares | Sole | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||